Trial Profile
Bupropion for Depression in ESRD Patients on Hemodialysis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Fluoxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- 16 Jul 2018 Status changed from recruiting to discontinued.
- 13 Sep 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 13 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Sep 2018.